American Century Companies’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
Other funds holding RIGL
SCM
AC
American Century Companies's RIGL Position: Q2 2026 in Review
American Century Companies increased its Rigel Pharmaceuticals (RIGL) stake by 36% in Q2 2026, buying an estimated $6.08M and bringing the position to 741,718 shares worth $29M. The position accounts for 0.01% of the portfolio, ranked #1100.
American Century Companies first reported a position in RIGL in Q2 2015 and has held it in 13 quarters since. 156 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.
- American Century Companies held 741,718 shares of Rigel Pharmaceuticals worth $29M as of Q2 2026.
- American Century Companies bought 197,287 Rigel Pharmaceuticals shares in Q2 2026, an estimated $6.08M.
- Rigel Pharmaceuticals made up 0.01% of American Century Companies's portfolio in Q2 2026, its #1100 holding.
- American Century Companies first reported a position in Rigel Pharmaceuticals in Q2 2015 and has held it in 13 quarters since.
- 156 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.